Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it’s wholly owned subsidiary, Dr Reddy’s Laboratories, Inc is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags to the hospital level in U.S.A. (US Food Recalls) More
A Product Recall on Whole Cucumbers Grocery.com
L&M Companies Inc. has announced a voluntary recall for its whole cucumber product due to a possible bacterial contamination. The recall was initiated after ...
Posted on 24 January 2017 | 3:00 am | Google News
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has expanded its strategic collaboration with Amgen, one.
Posted on 16 September 2016 | 2:00 am | Google News
Copyright © 2019 LastMinuteStuff.com